CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 246,487	$ 278,096
Short-term marketable securities	0	72,749
Related party receivables from collaborative arrangements	93,931	79,427
Prepaid expenses and other current assets	1,640	962
Total current assets	342,058	431,234
Property and equipment, net	28	33
Equity and other long-term investments	438,258	0
Capitalized fees paid to a related party, net	125,253	139,076
Deferred tax assets, net	93,759	154,171
Other assets	214	312
Total assets	999,570	724,826
Current liabilities:
Accounts payable	66	10
Accrued personnel-related expenses	490	647
Accrued interest payable	4,152	4,152
Other accrued liabilities	1,402	562
Total current liabilities	6,110	5,371
Long-term debt, net of discount and issuance costs	385,517	377,120
Other long-term liabilities	106	219
Commitments and contingencies (Note 9)
Stockholders' equity:
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding	0	0
Common stock: $0.01 par value, 200,000 shares authorized, 101,392 and 101,288 issued and outstanding as of December 31, 2020 and December 31, 2019, respectively	1,014	1,013
Additional paid-in capital	1,260,900	1,258,859
Accumulated other comprehensive income	0	27
Accumulated deficit	(722,002)	(946,404)
Total Innoviva stockholders' equity	539,912	313,495
Noncontrolling interest	67,925	28,621
Total stockholders' equity	607,837	342,116
Total liabilities and stockholders' equity	$ 999,570	$ 724,826